Publication of article in Eurosurveillance || Impact of sex and gender on post-COVID-19 syndrome, Switzerland, 2020 || EN

Publication of article in Eurosurveillance || Impact of sex and gender on post-COVID-19 syndrome, Switzerland, 2020 || EN

Women are overrepresented among individuals with post-acute sequelae of SARS-CoV-2 infection (PASC). Biological (sex) as well as sociocultural (gender) differences between women and men might account for this imbalance, yet their impact on PASC is unknown. We assessed the impact of sex and gender on PASC in a Swiss population.

Our multicentre prospective cohort study included 2,856 (46% women, mean age 44.2 ± 16.8 years) outpatients and hospitalised patients with PCR-confirmed SARS-CoV-2 infection.ResultsAmong those who remained outpatients during their first infection, women reported persisting symptoms more often than men (40.5% vs 25.5% of men; p < 0.001). This sex difference was absent in hospitalised patients. In a crude analysis, both female biological sex (RR = 1.59; 95% CI: 1.41-1.79; p < 0.001) and a score summarising gendered sociocultural variables (RR = 1.05; 95% CI: 1.03-1.07; p < 0.001) were significantly associated with PASC. Following multivariable adjustment, biological female sex (RR = 0.96; 95% CI: 0.74-1.25; p = 0.763) was outperformed by feminine gender-related factors such as a higher stress level (RR = 1.04; 95% CI: 1.01-1.06; p = 0.003), lower education (RR = 1.16; 95% CI: 1.03-1.30; p = 0.011), being female and living alone (RR = 1.91; 95% CI: 1.29-2.83; p = 0.001) or being male and earning the highest income in the household (RR = 0.76; 95% CI: 0.60-0.97; p = 0.030).

Specific sociocultural parameters that differ in prevalence between women and men, or imply a unique risk for women, are predictors of PASC and may explain, at least in part, the higher incidence of PASC in women. Once patients are hospitalised during acute infection, sex differences in PASC are no longer evident.

Link to article here

Publication of book || Gendermedizin in der klinischen Praxis || DE

Publication of book || Gendermedizin in der klinischen Praxis || DE

Noch immer ist nicht klar, warum Männer mehr und früher im Leben Herzinfarkte haben, aber jüngere Frauen ein höheres Risiko, an einem erlittenen Infarkt zu versterben. 90 % der plötzlichen Herztodesfälle beim Sport und die Mehrzahl der Kardiomyopathien und Myokarditiden betreffen Männer, aber die stressinduzierte Herzerkrankung, das Takotsubo-Syndrom, zu 90 % postmenopausale Frauen. In den Gefäß- und Herzzellen finden sich genetisch und hormonell verursachte Geschlechterunterschiede. Gender, Stress, Depression und das Zusammenspiel von Herz, Immunsystem und Gehirn beeinflussen das Auftreten und den Verlauf von Herzerkrankungen geschlechtsspezifisch. Blutdrucke im Verlauf des Lebens unterscheiden sich bei den Geschlechtern. Das Risiko von Schwangerschaftskomplikationen für Herz-Kreislauf-Erkrankungen (HKE) muss stärker berücksichtigt werden. Kardiovaskuläre Medikamente müssen für Männer und für Frauen optimiert werden. Frauen profitieren ebenso wie die Männer von interventioneller Therapie.
Link zum Buchkapitel 'Geschlechtsspezifische Aspekte bei Herz-Kreislauf-Erkrankungen' hier.

Congratulations to Adriana Vinzens!

Congratulations to Adriana Vinzens!

Warm congratulations to Adriana, who has completed her master's thesis on the topic "Prognostic Value of Perivascular Adipose Tissue Attenuation in Patients Undergoing Transcatheter Aortic Valve Implantation" with the highest grade at the University of Zurich!

Two Gebhard Labs Unite

Two Gebhard Labs Unite

After many years of successful collaboration in the field of Gender Medicine and Women’s Health in Switzerland, Caroline Gebhard, intensivist and anesthesiologist at the University Hospital Basel, and Catherine Gebhard, cardiologist at the University Hospital Bern and the University of Zurich, have united their research groups in order to accomplish together their common goal of reaching gender equality in medicine in Switzerland.

 

Inselspital Bern

Department of Cardiology
Freiburgstrasse 20
CH-3010 Bern

Stadtspital Zürich Triemli

Institut für Intensivmedizin
Birmensdorferstrasse 497
CH-8063 Zürich

University Hospital Zurich

Department of Nuclear Medicine
Cardiovascular Gender Medicine
Rämistrasse 100
CH-8091 Zurich

University of Basel
Department of Clinical Research

Petersgraben 4
CH-4031 Basel